Cedilla Therapeutics, Inc. logo

Cedilla Therapeutics, Inc.

Cedilla Therapeutics is a biotechnology company which is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.cedillatx.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
MA 02139
Cambridge
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/cedillatherapeutics” connections=”true” suffix=””]

The human proteomes which is highly interactive and dynamic system is utilized for protein stability. Its mechanism is being explored to govern protein stability to redirect the course of disesase. The aim is for disease-causing proteins to ultimately go through the protein shredder or get degraded through other.

In Apr 2018, Cedilla Therapeutics,was launched with $56.2 Mn in Series A funding from Third Rock Ventures.